Related Experiment Videos
Cranio-facial trauma and cerebral SPECT studies using N-isopropyl-iodo-amphetamine (123I)
J L Ducours1, C Role, J Guillet
1Department of Maxillo-facial Surgery, Centre Hospitalier, Agen, France.
Nuclear Medicine Communications
|May 1, 1990
Summary
Cerebral SPECT scans using N-isopropyl-iodo-amphetamine (123I) (IMP) reveal brain abnormalities in cranio-facial trauma patients, even with normal CT scans. IMP SPECT complements CT for diagnosing these injuries.
Area of Science:
- Neurology
- Radiology
- Nuclear Medicine
Background:
- Cranio-facial trauma can cause subtle brain injuries.
- Computed tomography (CT) may not detect all abnormalities.
Purpose of the Study:
- To evaluate the utility of cerebral SPECT with N-isopropyl-iodo-amphetamine (123I) (IMP) in patients with cranio-facial trauma.
- To compare IMP SPECT findings with CT scans.
Main Methods:
- Cerebral SPECT studies were performed using 123I-IMP in patients with cranio-facial trauma.
- Patients were categorized based on the presence or absence of loss of consciousness (LOC).
- Results were compared with conventional CT imaging.
Main Results:
- Nine out of ten patients with LOC showed normal CT scans but evident photopaenia on IMP SPECT.
- IMP SPECT identified abnormalities not seen on CT in patients with cranio-facial trauma and LOC.
Conclusions:
- 123I-IMP SPECT is a valuable tool for detecting cerebral perfusion deficits after cranio-facial trauma.
- IMP SPECT complements CT, improving the diagnostic accuracy for brain injuries in trauma patients.